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1. Introduction 
There are several reports in the literature suggesting 
a role of insulin in the regulation of the interconversion 
of pyruvate dehydrogenase (EC 1.2.4.1) between its 
active and inactive forms. In adipose tissue this 
hormone markedly increased the active dephospho 
form (PDHa) when applied in vivo or in vitro [l-4] . 
Also in liver a doubling of PDHa was observed shortly 
after insulin injection into normal rats [5]. Further- 
more, PDH dephosphorylation in rat heart muscle was 
impaired in alloxan diabetes [6]. Stimulation of 
PDH-phosphatase by insulin in adipose tissue has been 
described [4,7], but was not confirmed by others [8]. 
Therefore we present our results on the activity of this 
enzyme in freeze-clamped tissues from normal, 
hyperinsulinized and alloxan diabetic rats. Some of 
these data have been reported elsewhere [6] . 
2. Materials and methods 
Male Sprague-Dawley rats of 150-250. g 
(W. Gassner, Sulzfeld, Germany) were used. Induc- 
tion of alloxan diabetes and insulin substitution were 
performed as described 191. Preparation of tissue 
extracts: Organs were removed from rats under ether 
anaesthesia nd frozen immediately with the aid of a 
Wollenberger clamp pre-cooled in liquid Nz. The rats 
were then decapitated and the heads kept in liquid Ns 
until removal of the deep frozen brain. The organs 
were powdered in a Minidismembrator (Braun, 
Melsungen, Germany) driven at full speed for 30 set 
and kept in liquid Ns until extraction. For PDH- 
North-Holland Publishing Company - Amsterdam 
phosphatase xtraction 1 g of powdered brain, kidney 
or liver was suspended in 3 ml, 1 g of heart muscle in 
4 ml of 20 mM potassium phosphate buffer, pH 7.0, 
containing 1% Lubrol (ICI, Frankfurt, Germany) and 
5% serum from fed Wistar rats [lo] (medium A). 
Extraction from adipose tissue was performed by 
suspending 160 mg tissue powder with 0.4 ml of 
medium A and 2.4 ml silicon oil AK 20 (Wacker, 
Burghausen, Germany). The suspensions were 
thawed and homogenized in a high-speed tissue 
disintegrator (Ultra Turrax TP 18/2 Jahnke & Kunkel, 
Staufen i. Br., Germany) for 2 X 15 sec. The 
temperature did not exeed + 2°C. The homogenates 
were frozen, thawed and centrifuged for 2 min in an 
Eppendorf centrifuge (type 3200). The clear extracts 
were used for the enzyme assay. PDH-phosphatase 
assay by PDH reactivation: the reaction mixture 
consisting of 10 ~1 phospho-PDH (corresponding to 
126 mU dephospho-PDI-I) 5 ~1 of a 1: 1 mixture of 
100 n&l MgClz and 5 mM CaCls, 5 ,ul of medium A 
and 5 ~1 of tissue extract was incubated for 20 min 
at 25°C and then analyzed for PDH activity spectro- 
photometrically as described [ 1 l] using lactate as 
the substrate. The tissue extracts were diluted with 
medium A to ensure linearity of PDH reactivation 
with protein and time up to 40 min. Blanks were run 
without phospho-PDH to measure the endogenous 
PDH activity of the tissue extracts and without tissue 
extract to detect traces of PDH-phosphatase activity 
in the phospho-PDH preparation. The values of 
PDH-phosphatase activity reported are appropriately 
corrected. 
PDH-phosphatase assay by release of 32 Pi from 
[32P]phospho-PDH: the reaction mixture consisted 
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of 20 yl [32P]phospho-PDH (corresponding to about 
150 /_tg protein containing.1 nmol 32Pi, corresponding 
to about 0.6 U dephospho-PDH), 5 ~170 mM MgCl2 
or H20, 5 ~120 mM potassium phosphate buffer, 
pH 7.0, and 5 ~1 of tissue extract. After incubation 
for 5 min at 25°C 10 ~1 of the reaction mixture were 
mixed with 20 ~1 6% HC104 (w/v). After centrifuga- 
tion the radioactivity in the supernatant was.determined 
in a Packard liquid scintillation counter. The 32 Pi 
release due to Mg2’ was taken as a measure of phos- 
phatase activity. (The addition of Ca”(up to 0.7 mM) 
or rat serum to the incubation mixture did not change 
the results). 
Glutamate dehydrogenase (GDH) (EC 1.4.1.2), 
citrate synthase (CS) (EC 4.1.3.75, lactate dehydro- 
genase (LDH) (EC 1.1.1.27) and pyruvate kinase 
(PK) (EC 2.7.1.40) were assayed by standard methods 
[ 121. PDH activity of tissue fractions was measured 
according to [5] . 
Protein was determined by the biuret method [ 171 
employing KCN to correct for turbidity [ 181. 
3. Results and discussion 
The PDH-phosphatase activity in organs from Thus it appears that most of the dephosphorylating 
normal, hyperinsulinized and alloxan-diabetic rats activity of a liver homogenate is not related to phospho 
has been determined. The values found in kidney, PDH reactivation. True PDH-phosphatase activity of 
heart muscle, liver, brain and epididymal adipose 
tissue are summarized in table 1. Per gram fresh 
weight or unit of glutamate dehydrogenase activity 
(not shown) neither hyperinsulinism nor insulin 
deficiency caused a statistically significant effect on 
PDH-phosphatase activity of any of the tissue extracts 
examined by its potency to reactivate exogenous 
phospho-PDH. Also no difference between normal 
and diabetic rats was found by following the release 
of 32Pi from [32P]phospho PDH (table 2). The validity 
of the latter method for PDH-phosphatase measurement 
however became dubious by the results obtained when 
the subcellular distribution of PDH-phosphatase in 
liver was studied with both methods. When tested by 
phospho-PDH reactivation the bulk of the phosphatase 
activity of a liver homogenate was recovered in the 
mitochondrial fraction together with glutamate 
dehydrogenase, citrate synthase and PDH (table 3). 
A completely different enzyme distribution pattern 
was obtained when the phosphatase measurement 
was attempted by [32P] phospho-PDH dephosphoryla- 
tion (fig. 1). Only 18.9 + 3.5% (n = 3) of total [32P] 
phospho-PDH dephosphorylating activity of a liver 
homogenate was found in the mitochondrial fraction, 
69.4 f 3.6% (n = 3) being in the cytosol. 
Table 1 
Activity of pyruvate dehydrogenase phosphatase in tissue extracts from normal, hyperinsulinized and diabetic rats 
Blood 
glucose 
(mg/lOO ml) 
117* 2 
(9) 
68+ 6 
(9) 
44+ 6 
(4) 
422 f 32 
(5) 
Experimental 
group 
Control 
Hyperinsulin- 
izeda 
Alloxan-diabetic 
(insulin-treated) 
Alloxan-diabetic 
(insulin withdrawn 
for 36 h) 
Kidney Heart muscle Liver Adipose tissue Brain 
391 + 15.4 
(6) 
379 i 20.9 
(5) 
360 f 29.6 
(4) 
421 + 43.7 
(5) 
413 f 73.1 
(5) 
456 * 64.1 
(6) 
477 f 76.3 
(4) 
593 k 75.1 
(5) 
170 c 15 
(9) 
162k 16 
(9) 
222 + 24.4 
(4) 
221 f 26.6 
(5) 
40.0 + 4.5 
(9) 
39.7 f 5.0 
(9) 
59.8 f 11.3 
(4) 
54.6 + 10.3 
(5) 
480 + 24.9 
(6) 
414 * 31.5 
(6) 
530 f 39.0 
(4) 
438 * 28.5 
(4) 
For details see Materials and methods. The results, expressed as mU/g fresh wt., are given as mean f s.e.m. for the number of 
animals given in parentheses. The unit of phosphatase activity is defined by reactivation of one unit of phospho-PDH per min 
at 25°C. 
aAnimals received 10 U Altinsulin Hoechst i.p. 30 min before sacrifice, the control group was injected withsaline. 
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Fig.1. Release of =Pi from pig heart [ “Plphospho-PDH by the cytosolic and mitochondrial fractions of a normal fed rat liver. 
The cytosolic extracts (El, EII, EIII) and the mitochondrial extract (E) were prepared according to Pette [ 151 except that 
0.3 M sucrose in 20 mM potassium phosphate buffer, pH 7.0, was used. Of theradioactivity released by the supernatant or the 
mitochondrial fraction 93% and 102% respectively was eluted from Dowex 1 [ 161 by 2 N formic acid together with 
reference Pi. (P) ~Pi releasing activity; (LDH) lactate dehydrogenase; (PK) pyruvate kinase; (CS) citrate synthase; (GDH) 
glutamate dehydrogenase. 
tissue extracts should therefore be assayed rather by 
PDH reactivation than by 32Pi release from labeled 
PDH. Whether [32P] phospho-PDH dephosphoryla- 
tion without reactivation occurs also in other 
tissues than liver has not been studied so far. Stansbie 
et al. [ 131, however, have claimed that in epididymal 
adipose tissue 80% of the PDH-phosphatase activity 
is localized in the extramitochondrial space. Since 
this observation was made by only following 32Pi 
release from exogenous [“PI phospho-PDH the 
question arises from our results with liver whether 
the cytosolic fraction of adipose tissue in fact contains 
PDH-phosphatase, i.e. an enzyme capable of reactivat- 
ing phospho-PDH. According to Reed et al., PDH 
contains two seryl groups which are phosphorylated 
by PDH-kinase [ 191. The one which is rapidly phos- 
phorylated is essential for catalytic activity, while the 
second, reacting more slowly, does not correlate with 
enzyme activity. Thus the possibility exists that 32Pi 
released from [32P]phospho-PDH by the cytosolic 
fraction of liver and possibly other tissues stems from 
seryl residues not involved in PDH inactivation. 
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